PAPER Borson S, Frank L, Bayley PJ, Boustani M, Dean M, Lin PJ, McCarten JR, Morris JC, Salmon DP, Schmitt FA, Stefanacci RG, Mendiondo MS, Peschin S, Hall EJ, Fillit H, Ashford JW
SEARCH RESULTS
330913 RESULTS
PAPER Guzman VA, Carmichael OT, Schwarz C, Tosto G, Zimmerman ME, Brickman AM,
White matter hyperintensities and amyloid are independently associated with entorhinal cortex volume among individuals with mild cognitive impairment.
Alzheimers Dement. 2013 Oct;9(5 Suppl):S124-31. PubMed: 23375566PAPER Jessen F, Wolfsgruber S, Wiese B, Bickel H, Mösch E, Kaduszkiewicz H, Pentzek M, Riedel-Heller SG, Luck T, Fuchs A, Weyerer S, Werle J, van den Bussche H, Scherer M, Maier W, Wagner M,
AD dementia risk in late MCI, in early MCI, and in subjective memory impairment.
Alzheimers Dement. 2013 Jan 30; PubMed: 23375567PAPER Previc FH
Vestibular loss as a contributor to Alzheimer's disease.
Med Hypotheses. 2013 Apr;80(4):360-7. PubMed: 23375669PAPER Kantarci K, Gunter JL, Tosakulwong N, Weigand SD, Senjem MS, Petersen RC, Aisen PS, Jagust WJ, Weiner MW, Jack CR,
Focal hemosiderin deposits and β-amyloid load in the ADNI cohort.
Alzheimers Dement. 2013 Oct;9(5 Suppl):S116-23. PubMed: 23375568PAPER Dodel R, Rominger A, Bartenstein P, Barkhof F, Blennow K, Förster S, Winter Y, Bach JP, Popp J, Alferink J, Wiltfang J, Buerger K, Otto M, Antuono P, Jacoby M, Richter R, Stevens J, Melamed I, Goldstein J, Haag S, Wietek S, Farlow M, Jessen F
Intravenous immunoglobulin for treatment of mild-to-moderate Alzheimer's disease: a phase 2, randomised, double-blind, placebo-controlled, dose-finding trial.
Lancet Neurol. 2013 Mar;12(3):233-43. Epub 2013 Jan 31 PubMed: 23375965PAPER Holmes C
Intravenous immunoglobulin for Alzheimer's disease.
Lancet Neurol. 2013 Mar;12(3):218-9. PubMed: 23375966PAPER Brayda-Bruno L, Mons N, Yee BK, Micheau J, Abrous DN, Nogues X, Marighetto A
Partial loss in septo-hippocampal cholinergic neurons alters memory-dependent measures of brain connectivity without overt memory deficits.
Neurobiol Dis. 2013 Jun;54:372-81. PubMed: 23376311PAPER Hermann D, Mezler M, Müller MK, Wicke K, Gross G, Draguhn A, Bruehl C, Nimmrich V
Synthetic Aβ oligomers (Aβ1-42 globulomer) modulate presynaptic calcium currents: Prevention of Aβ-induced synaptic deficits by calcium channel blockers.
Eur J Pharmacol. 2013 Feb 28;702(1-3):44-55. PubMed: 23376566PAPER Zimny A, Bladowska J, Neska M, Petryszyn K, Guziński M, Szewczyk P, Leszek J, Sąsiadek M
Quantitative MR evaluation of atrophy, as well as perfusion and diffusion alterations within hippocampi in patients with Alzheimer's disease and mild cognitive impairment.
Med Sci Monit. 2013;19:86-94. PubMed: 23377218PAPER Czapski GA, Maruszak A, Styczynska M, Zekanowski C, Safranow K, Strosznajder JB
Association between plasma biomarkers, CDK5 polymorphism and the risk of Alzheimer's disease.
Acta Neurobiol Exp (Wars). 2012;72(4):397-411. PubMed: 23377270PAPER Chhangani D, Mishra A
Protein Quality Control System in Neurodegeneration: A Healing Company Hard to Beat but Failure is Fatal.
Mol Neurobiol. 2013 Feb 3; PubMed: 23378031PAPER Prokopiadou D, Papadakaki M, Roumeliotaki T, Komninos ID, Bastas C, Iatraki E, Saridaki A, Tatsioni A, Manyon A, Lionis C
Translation and Validation of a Questionnaire to Assess the Diagnosis and Management of Dementia in Greek General Practice.
Eval Health Prof. 2013 Feb 1; PubMed: 23378485PAPER Ismail MF, Elmeshad AN, Salem NA
Potential therapeutic effect of nanobased formulation of rivastigmine on rat model of Alzheimer's disease.
Int J Nanomedicine. 2013;8:393-406. PubMed: 23378761PAPER Katsuda T, Tsuchiya R, Kosaka N, Yoshioka Y, Takagaki K, Oki K, Takeshita F, Sakai Y, Kuroda M, Ochiya T
Human adipose tissue-derived mesenchymal stem cells secrete functional neprilysin-bound exosomes.
Sci Rep. 2013;3:1197. PubMed: 23378928Current Filters
No filters selected